BCAX compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name

BCAXBicara Therapeutics Inc.

Mkt capRevenueRevenue

ASNDAscendis Pharma A/S

Mkt capRevenueRevenue

Compare

BCAXBicara Therapeutics Inc.

ASNDAscendis Pharma A/S

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

BCAX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−14.32%—

May 11 '26±19.1%▲+1.51%×0.08

Q1 FY26±13.5%▲+3.65%×0.27

Q3 FY25±29.2%▼−4.85%×0.16

ASND

No earnings history for ASND.

= impliedBCAX realized, solidASND realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

BCAXBicara Therapeutics Inc.

9.11▼−6.38%· post 8.91

Mkt cap$620.2M

ASNDAscendis Pharma A/S

252.96▼−0.02%· post 251.31

ClosedOct 30 '26

Mkt cap$15.6B

Compare

ClosedOct 30 '26

BCAXBicara Therapeutics Inc.

ASNDAscendis Pharma A/S

9.11▼−6.38%post 8.91

Price

252.96▼−0.02%post 251.31

$620.2M

Mkt cap

$15.6B

BCAX9.11▼−6.38%vsASND252.96▼−0.02%ClosedOct 30 '26